Edaravone Nanoparticles

Varatharajan Rajavel

ISBN 10: 3659851833 / ISBN 13: 9783659851834

Published by LAP LAMBERT Academic Publishing Sep 2017, 2017

About this Item

Neuware -Objective of the present study is to prepare edaravone nanoparticle by using 3 level factorial deign using design expect 9 software. The software produced 17 formulations with varying concentration of EC, PVA and Tween-80 with a fixed dose of edaravone (5 mg). The drug and polymer compatibility study was done by FTIR spectroscopy. All the 17 formulations morphology was spherical in shape and the zeta potential in the rage of -12.7 mV to -28.5 mV. The particle size and entrapment efficiency was the main independent variable in formula optimization. The in-vitro dissolution of all the formulations were followed initial burst release followed by sustained release more than 12 hours. Based on the factorial design studies, we optimized formulation of edaravone nanoparticle. 84 pp. Englisch.

Seller Inventory # 9783659851834

Bibliographic Details

• Title: Edaravone Nanoparticles
• Publisher: LAP LAMBERT Academic Publishing Sep 2017
• Publication Date: 2017
• Language: English
• ISBN 10: 3659851833
• ISBN 13: 9783659851834
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 6D millimeters 220 millimeters width by 150 millimeters height by 6 millimeters depth
• Weight: 143 grams

About this title

Synopsis

Objective of the present study is to prepare edaravone nanoparticle by using 3 level factorial deign using design expect 9 software. The software produced 17 formulations with varying concentration of EC, PVA and Tween-80 with a fixed dose of edaravone (5 mg). The drug and polymer compatibility study was done by FTIR spectroscopy. All the 17 formulations morphology was spherical in shape and the zeta potential in the rage of -12.7 mV to -28.5 mV. The particle size and entrapment efficiency was the main independent variable in formula optimization. The in-vitro dissolution of all the formulations were followed initial burst release followed by sustained release more than 12 hours. Based on the factorial design studies, we optimized formulation of edaravone nanoparticle.

About the Author

Dr.Varatharajan Rajavel has been completed M.Pharm in Industrial Pharmacy, Annamalai University, India and PhD in Pharmacology, University of Malaya, Kuala Lumpur, Malaysia. Presently working as a Associate Professor in Faculty of Pharmacy, Asian Institute of Medicine and Technology University (AIMST), Kedah, Malaysia.